224 related articles for article (PubMed ID: 31881026)
21. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
22. Comparison of QuantiFERON-TB Gold with tuberculin skin test for detection of latent tuberculosis infection before kidney transplantation.
Kim JS; Cho JH; Park GY; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
Transplant Proc; 2013 Oct; 45(8):2899-902. PubMed ID: 24157000
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and risk factors for latent tuberculosis among diabetes patients in Taiwan: A cross-sectional study.
Chang A; Wu CZ; Lin JD; Lee CN; Tsai KY; Wu PH; Hsieh AT
J Infect Dev Ctries; 2022 Apr; 16(4):644-649. PubMed ID: 35544626
[TBL] [Abstract][Full Text] [Related]
24. Screening for latent tuberculosis infection in psoriasis and psoriatic arthritis patients in a tuberculosis-endemic country: a comparison of the QuantiFERON®-TB Gold In-Tube test and tuberculin skin test.
Duman N; Ersoy-Evans S; Karadağ O; Aşçıoğlu S; Sener B; Kiraz S; Sahin S
Int J Dermatol; 2014 Oct; 53(10):1286-92. PubMed ID: 25039468
[TBL] [Abstract][Full Text] [Related]
25. No need to change the drug class: ixekizumab- following secukinumab-therapy in psoriasis.
Bokor-Billmann T; Schäkel K
J Dermatolog Treat; 2019 May; 30(3):216-220. PubMed ID: 30051725
[TBL] [Abstract][Full Text] [Related]
26. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
[TBL] [Abstract][Full Text] [Related]
27. QuantiFERON-TB Gold In-Tube Test in the Diagnosis of Latent Tuberculosis Infection in Arthritis Patients Treated with Tumor Necrosis Factor Antagonists.
Baričević D; Popović Grle S; Morović Vergles J; Čuković Čavka S; Jakopović M; Redžepi G; Boras Z; Baričević M; Samaržija M
Acta Clin Croat; 2017 Jun; 56(2):203-209. PubMed ID: 29485786
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers.
Saraceno R; Specchio F; Chiricozzi A; Sarmati L; Amicosante M; Chimenti MS; Chimenti S
Expert Opin Biol Ther; 2014 Feb; 14(2):151-6. PubMed ID: 24303977
[TBL] [Abstract][Full Text] [Related]
29. Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy.
Gisondi P; Pezzolo E; Lo Cascio G; Girolomoni G
Br J Dermatol; 2014 Oct; 171(4):884-90. PubMed ID: 24863903
[TBL] [Abstract][Full Text] [Related]
30. Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients.
Ryu MR; Park MS; Cho EH; Jung CW; Kim K; Kim SJ; Oh HY; Huh W; Jang HR; Koh WJ; Park HY; Kim YH; Sinn DH; Choi JO; Joh JW; Kim JM; Kim SJ; Park JB; Kang ES
J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30135226
[TBL] [Abstract][Full Text] [Related]
31. Response to IL-17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein-coding and untranslated regions of the IL-17A gene: results from a multicentre study of four European psoriasis cohorts.
van Vugt LJ; van den Reek JMPA; Meulewaeter E; Hakobjan M; Heddes N; Traks T; Kingo K; Galluzzo M; Talamonti M; Lambert J; Coenen MJH; de Jong EMGJ
J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):112-118. PubMed ID: 31287604
[TBL] [Abstract][Full Text] [Related]
32. IL-1RA in the supernatant of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus is useful for discriminating active tuberculosis from latent infection.
Akashi S; Suzukawa M; Takeda K; Asari I; Kawashima M; Ohshima N; Inoue E; Sato R; Shimada M; Suzuki J; Yamane A; Tamura A; Ohta K; Tohma S; Teruya K; Nagai H
J Infect Chemother; 2021 Apr; 27(4):617-624. PubMed ID: 33317988
[TBL] [Abstract][Full Text] [Related]
33. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
Sato S; Nagai H
Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
[TBL] [Abstract][Full Text] [Related]
34. QuantiFERON TB-gold conversion rate among psoriasis patients under biologics: a 9-year retrospective study.
Megna M; Ferrillo M; Ruggiero A; Cinelli E; Gallo L; Fabbrocini G
Int J Dermatol; 2021 Mar; 60(3):352-357. PubMed ID: 32989759
[TBL] [Abstract][Full Text] [Related]
35. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY
Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil.
Steffen RE; Caetano R; Pinto M; Chaves D; Ferrari R; Bastos M; de Abreu ST; Menzies D; Trajman A
PLoS One; 2013; 8(4):e59546. PubMed ID: 23593145
[TBL] [Abstract][Full Text] [Related]
37. Association of clinical properties and compatibility of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test in patients with psoriasis.
Karataş Toğral A; Muştu Koryürek Ö; Şahin M; Bulut C; Yağci S; Ekşioğlu HM
Int J Dermatol; 2016 Jun; 55(6):629-33. PubMed ID: 26498894
[TBL] [Abstract][Full Text] [Related]
38. Serial interferon-γ release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents.
Scrivo R; Sauzullo I; Mengoni F; Iaiani G; Vestri AR; Priori R; Di Filippo E; Di Franco M; Spinelli FR; Vullo V; Mastroianni CM; Valesini G
Clin Rheumatol; 2012 Nov; 31(11):1567-75. PubMed ID: 22864811
[TBL] [Abstract][Full Text] [Related]
39. QuantiFERON-TB Gold In-Tube test conversions and reversions among tuberculosis patients and their household contacts in Addis Ababa: a one year follow-up study.
Belay M; Legesse M; Dagne D; Mihret A; Bekele Y; Medhin G; Bjune G; Abebe F
BMC Infect Dis; 2014 Dec; 14():654. PubMed ID: 25466365
[TBL] [Abstract][Full Text] [Related]
40. Performance of QuantiFERON-TB Gold In-Tube test and Tuberculin Skin Test for diagnosis of latent tuberculosis infection in BCG vaccinated health care workers.
Babayigit C; Ozer B; Ozer C; Inandi T; Duran N; Gocmen O
Med Sci Monit; 2014 Mar; 20():521-9. PubMed ID: 24681806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
